Neoleukin Therapeutics
Why Robinhood?
You can watch NLTX and buy or sell other stocks, ETFs, and their options commission-free!About NLTX
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NLTX Key Statistics
Stock Snapshot
As of today, Neoleukin Therapeutics(NLTX) shares are valued at $30.09. The company's market cap stands at 466.09M, with a P/E ratio of -4.10.
On 2026-03-31, Neoleukin Therapeutics(NLTX) stock opened at —, reached a high of —, and a low of —.
The Neoleukin Therapeutics(NLTX)'s current trading volume is 0, compared to an average daily volume of 175.89K.
During the past year, Neoleukin Therapeutics(NLTX) stock moved between $6.88 at its lowest and $37.27 at its peak.
During the past year, Neoleukin Therapeutics(NLTX) stock moved between $6.88 at its lowest and $37.27 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.